(Q52245488)

English

A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials.

scientific article published in March 1998

Statements

A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit